Sirona Dx was founded to accelerate the pace of targeted therapy development to improve outcomes for cancer patients. Our technology agnostic CRO offers specialized high complexity genomics and proteomics services supporting pharmaceutical companies with their drug discovery and development programs.
Sirona Dx operates a CLIA certified facility and collaborates with leading platform providers including ThermoFisher, illumina, Fluidigm and nanoString to offer advanced technologies and the most comprehensive menu of high parameter IO expression profiling assays to explore tumor immunobiology and identify new biomarkers. We have leading expertise in the extraction of RNA from challenging sample types including FFPE enabling our pharma clients to profile more of their precious samples.
Our experienced team offers expertise for clinical protocol design combined with a variety of customized reporting, clinical trial site training, and investigator support.